受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2017 Batch: A201702
Spartalizumab is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1. It binds to PD-1 with high affinity and inhibits the biological activity of PD-1, MW: 145.8 KD.
CAS No. | 1935694-88-4 |
---|---|
Formulation | PBS buffer, pH 7.2 |
Isotype | Human IgG4 |
Source | CHO cells |
Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
Shipping | Shipped under low temperature conditions |
Purity | 98.4% |
Protein concentration | 5.0 mg/ml |
Endotoxin Level | ≤1 EU/mg |
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. [ Elife, 2020, 9] | PubMed: 32091388 |
人間や獣医の診断であるか治療的な使用のためにでない。